Amerge and Pregnancy and Nursing

Taking Amerge During Pregnancy—Pregnancy Category C

There are no adequate studies on the effects of using Amerge during pregnancy. In animals, pregnant animals treated with Amerge had some babies with problems. That’s why you should only use Amerge during pregnancy if the potential benefit is greater than the potential risk to your unborn child. If you are pregnant, or think you might be pregnant, talk to your doctor about using Amerge.

You can also check to see if there is an Amerge pregnancy exposure registry for that medicine. The Food and Drug Administration has a list of pregnancy exposure registries (http://www.fda.gov/womens/registries/default.htm) where pregnant women can find information.

Pregnancy Registry: To monitor fetal outcomes of pregnant women exposed to Amerge, GlaxoSmithKline maintains an Amerge Pregnancy Registry. If you are pregnant and taking Amerge, you may want to talk to your doctor about becoming part of the registry. Your doctor can register you by calling (800) 336-2176.

 

Amerge While Breast Feeding

Amerge should be used with caution in women who are nursing. In animal studies, some of the medicine in Amerge has crossed over from the mother’s body into her breast milk. Do not use Amerge while breast feeding unless you have gotten your doctor’s approval to do so.

Written & reviewed by: Lisa Erwin R.Ph. CGP | Last review date: Dec 2010. Click the References Link below for a complete list of references.

Written & reviewed by: Lisa Erwin R.Ph. CGP | Last review date: Dec 2010.
View References